Author

Jayne Smith‐Palmer

Observed names: J Smith-Palmer, J. Smith-Palmer, J. Smith-palmer, J. Smith‐Palmer, Jayne Smith-Palmer, Smith-Palmer, Jayne

Institution: Covalence Research

Observed institutions: IQVIA (United States), Covalence Research, National Institute for Medical Research

ORCID: 0000-0001-6049-1241

Observed ORCID: 0000-0001-6049-1241

OpenAlex ID: A5019471615

Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes

2014 · J. Smith-Palmer, M. Brändle, et al. · Diabetes Research and Clinical Practice · 214

Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits

2015 · Jayne Smith-Palmer, Karin Cerri, et al. · BMC Infectious Diseases · 189

PDF

Impact of Stigma on People Living with Chronic Hepatitis B

2020 · Jayne Smith-Palmer, Karin Cerri, et al. · Patient Related Outcome Measures · 128

PDF

Evaluating the Health Economic Implications and Cost-Effectiveness of Dental Implants: A Literature Review

2013 · Robert Vogel, Jayne Smith-Palmer, et al. · The International Journal of Oral & Maxillofacial Implants · 106

Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada

2019 · J. Smith-Palmer, C. Takizawa, et al. · BMC Urology · 84

Cost‐effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review

2015 · S. Roze, J. Smith‐Palmer, et al. · Diabetic Medicine · 81

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

2013 · Rémi Marty, Stéphane Roze, et al. · BMC Cancer · 81

PDF

Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes

2016 · Jayne Smith-Palmer, Jay Bae, et al. · ClinicoEconomics and Outcomes Research · 57

PDF

Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes

2019 · Johan Jendle, Johannes Pöhlmann, et al. · Diabetes Technology & Therapeutics · 56

Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.

2020 · Stéphane Roze, John Isitt, et al. · Diabetes Care · 48

Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective

2015 · Stéphane Roze, Jayne Smith-Palmer, et al. · Journal of Medical Economics · 42

PDF

Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France

2015 · Stéphane Roze, Jayne Smith-Palmer, et al. · Diabetes Technology & Therapeutics · 37

Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost‐effectiveness analysis in the German setting

2009 · T. Mittendorf, J. Smith‐Palmer, et al. · Diabetes Obesity and Metabolism · 35

Review of the Clinical and Economic Burden of Antibody-Mediated Rejection in Renal Transplant Recipients

2016 · Gorden Muduma, Isaac Odeyemi, et al. · Advances in Therapy · 34

Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France

2020 · Stéphane Roze, John J. Isitt, et al. · Diabetes Therapy · 28

PDF

Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark

2017 · S. Roze, S. de Portu, et al. · Diabetes Research and Clinical Practice · 24

Influence of renal function on long-term graft survival and patient survival in renal transplant recipients

2013 · J. Smith-Palmer, A. Kalsekar, et al. · Current Medical Research and Opinion · 24

PDF

A systematic literature review and meta‐analysis of real‐world evidence on commercially available automated insulin delivery systems in people with type 1 diabetes

2025 · Johannes Pöhlmann, Jayne Smith‐Palmer, et al. · Diabetes Obesity and Metabolism · 22

Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands

2016 · S. Roze, E. Duteil, et al. · Journal of Medical Economics · 22

PDF

Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden

2017 · Johan Jendle, Jayne Smith-Palmer, et al. · Diabetes Therapy · 21

PDF

A European Cost–Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes

2023 · Johan Jendle, Maria Ida Buompensiere, et al. · Diabetes Technology & Therapeutics · 18

Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada

2021 · Stephane Roze, John J Isitt, et al. · ClinicoEconomics and Outcomes Research · 17

PDF

Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China

2010 · James L. Palmer, Amélie Beaudet, et al. · Advances in Therapy · 17

Lutetium oxodotreotide (177Lu-Dotatate) for the treatment of unresectable or metastatic progressive gastroenteropancreatic neuroendocrine tumors: a cost-effectiveness analysis for Scotland

2021 · J. Smith-Palmer, O. R. Leeuwenkamp, et al. · BMC Cancer · 15

PDF

Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia

2008 · Mohammed Ali, Jeremy White, et al. · Journal of Medical Economics · 15

Works count: 61

Citation count: 1,574

H-index: 20

I10-index: 33